Janus International Group Reports Second Quarter 2022 Financial Results
Janus International Group, Inc. (NYSE: JBI) reported a robust 42.2% revenue growth in Q2 2022, totaling $247.7 million, driven by strong sales across all channels. Adjusted EBITDA surged by 41.1% to $50.7 million, with a sequential margin improvement of 100 basis points. Net income reached $22.8 million, a significant turnaround from a loss in the previous year. The company raised its full-year 2022 revenue and Adjusted EBITDA guidance, now projecting revenue between $940 million and $960 million and Adjusted EBITDA between $204 million and $211 million, reflecting strong operational momentum.
- 42.2% revenue growth to $247.7 million compared to Q2 2021.
- Adjusted EBITDA increased by 41.1% to $50.7 million.
- Net income rose to $22.8 million from a loss in Q2 2021.
- Raised full-year 2022 revenue guidance to $940 million - $960 million.
- Raised Adjusted EBITDA guidance to $204 million - $211 million.
- Adjusted EBITDA margin decreased by approximately 10 basis points from the prior year.
- Free cash flow decreased to $16.0 million from $17.6 million in Q2 2021.
Delivered
Delivered over
Sequential Adjusted EBITDA margin improvement of approximately 100 basis points from Q1 2022 and over 200 basis points from Q4 2021
Sequential Net Income growth of approximately
Raises full-year 2022 revenue and Adjusted EBITDA outlook
Second Quarter 2022 Highlights
-
Revenues of
, a$247.7 million 42.2% increase compared to for the second quarter of 2021, driven primarily by strong performance across all sales channels, including Commercial and Other up$174.2 million 81.6% , Restore, Rebuild & Replace (“R3”) up34.3% , andNew Construction up17.3% , along with a contribution from the 2021 acquisitions of DBCI and ACT.$25.8 million
-
Adjusted EBITDA (defined as net income plus the corresponding add-backs shown in the Adjusted EBITDA reconciliation tables below) of
, a$50.7 million 41.1% increase compared to for the second quarter of 2021, driven by increased revenue from all sales channels, partially offset by incremental general and administrative expenses. Adjusted EBITDA as a percentage of revenues was$35.9 million 20.5% , a decrease of approximately 10 basis points from the prior year period due primarily to higher costs impacting raw material, labor and logistics in advance of commercial actions and productivity initiatives taking full effect, as well as incremental costs associated with being a public company. However, as a result of volume growth, productivity initiatives and commercial actions, Adjusted EBITDA margins increased by approximately 100 basis points over the first quarter of 2022 and over 200 basis points over the fourth quarter of 2021.
-
Net income was
, or$22.8 million per diluted share, compared to a$0.16 loss, or$1.7 million per diluted share in the second quarter of 2021.$(0.02)
-
Adjusted Net Income (defined as Net Income plus the corresponding tax-adjusted add-backs shown in the Adjusted Net Income reconciliation tables below) of
, up$24.8 million 20.4% compared to in the second quarter of 2021. Adjusted Net Income per diluted share was$20.6 million , compared to$0.17 per diluted share in the prior year quarter. The decrease in Adjusted Net Income per diluted share versus the prior year quarter was due to the increase in the weighted average number of outstanding shares as a result of the business combination in June of 2021, partially offset by higher Adjusted Net Income.$0.25
-
Operating cash flow of
compared to$18.4 million in the second quarter of 2021. Free cash flow was$19.3 million compared to$16.0 million in the second quarter of 2021, reflecting continued strong free cash flow conversion of$17.6 million 65% of Adjusted Net Income, despite the continued investments in working capital to support the ongoing growth of the business.
- Quarter end leverage ratio of 3.9x – a decrease of 0.4x from Q1 2022, with continued focus on de-levering the business towards goal of 2.5x - 3.5x.
2022 Financial Outlook:
Based on the Company’s current business outlook, Janus is raising its full-year 2022 outlook as follows:
-
Revenue in a range of
to$940 million , up from the previous range of$960 million to$890 million . The new range represents a$910 million 26.6% increase at the midpoint as compared to 2021 levels.
-
Adjusted EBITDA in a range of
to$204 million , up from the previous range of$211 million to$193 million . The new range represents a$200 million 40.0% increase at the midpoint as compared to 2021 levels.
About
Conference Call and Webcast
The Company will host a conference call and webcast to review first quarter results, discuss recent events and conduct a question-and-answer session on
Forward Looking Statements
Certain statements in this communication, including the estimated guidance provided under “2022 Financial Outlook” herein, may be considered “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact included in this communication are forward-looking statements, including, but not limited to statements regarding Janus’s positioning in the industry to strengthen its pipeline and deliver on its objectives and Janus’s belief regarding the demand outlook for Janus’s products and the strength of the industrials markets. When used in this communication, words such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions, as they relate to the management team, identify forward-looking statements. Such forward-looking statements are based on the current beliefs of Janus’s management, based on currently available information, as to the outcome and timing of future events, and involve factors, risks, and uncertainties that may cause actual results in future periods to differ materially from such statements.
In addition to factors previously disclosed in Janus’s reports filed with the
There can be no assurance that the events, results, trends or guidance regarding financial outlook identified in these forward-looking statements will occur or be achieved. Forward-looking statements speak only as of the date they are made, and Janus is not under any obligation and expressly disclaims any obligation, to update, alter or otherwise revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. This communication is not intended to be all-inclusive or to contain all the information that a person may desire in considering an investment in Janus and is not intended to form the basis of an investment decision in Janus. All subsequent written and oral forward-looking statements concerning Janus or other matters and attributable to Janus or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above and under the heading “Risk Factors” in Janus’s most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q, as updated from time to time in amendments and its subsequent filings with the
Non-GAAP Financial Measures
Janus uses measures of performance that are not required by or presented in accordance with GAAP in
Adjusted EBITDA, Adjusted Net Income, Adjusted Basic EPS, and Adjusted Diluted EPS are non-GAAP financial measures used by Janus to evaluate its operating performance, generate future operating plans, and make strategic decisions, including those relating to operating expenses and the allocation of internal resources. Accordingly, Janus believes Adjusted EBITDA, Adjusted Net Income, Adjusted Basic EPS, and Adjusted Diluted EPS provide useful information to investors and others in understanding and evaluating Janus’s operating results in the same manner as its management and board of directors and in comparison with Janus’s peer group companies. In addition, Adjusted EBITDA, Adjusted Net Income, Adjusted Basic EPS, and Adjusted Diluted EPS provide useful measures for period-to-period comparisons of Janus’s business, as they remove the effect of certain non-recurring events and other non-recurring charges, such as acquisitions, and certain variable or non-recurring charges. Adjusted EBITDA is defined as net income excluding interest expense, income taxes, depreciation expense, amortization, and other non-operational, non-recurring items. Adjusted Net Income is defined as net income plus the corresponding tax-adjusted add-backs shown in the Adjusted EBITDA reconciliation. Adjusted Basic earnings (income) per share (EPS) is computed by taking Adjusted Net Income divided by the weighted average number of shares of common stock outstanding during the period. Adjusted Diluted earnings (income) per share (EPS) is computed by dividing Adjusted Net Income by the weighted average number of common shares outstanding plus the effect of dilutive potential common shares outstanding during the period using the treasury stock method. Dilutive potential common shares include stock purchase warrants and contingently issuable shares attributable to the earn-out consideration.
Adjusted EBITDA, Adjusted Net Income, Adjusted Basic EPS, and Adjusted Diluted EPS should not be considered in isolation of, or as an alternative to, measures prepared in accordance with GAAP. There are a number of limitations related to the use of Adjusted EBITDA, Adjusted Net Income, Adjusted Basic EPS, and Adjusted Diluted EPS rather than net income (loss), which is the nearest GAAP equivalent of Adjusted EBITDA and Adjusted Net Income, or Basic EPS and Diluted EPS, which is the nearest equivalent to Adjusted Basic EPS and Adjusted Diluted EPS. These limitations include that the non-GAAP financial measures: (i) exclude depreciation and amortization, and although these are non-cash expenses, the assets being depreciated may be replaced in the future; (ii) do not reflect interest expense, or the cash requirements necessary to service interest on debt, which reduces cash available; (iii) do not reflect the provision for or benefit from income tax that may result in payments that reduce cash available; (iv) exclude non-recurring items (i.e., the extinguishment of debt); and (v) may not be comparable to similar non-GAAP financial measures used by other companies, because the expenses and other items that Janus excludes in the calculation of these non-GAAP financial measures may differ from the expenses and other items, if any, that other companies may exclude from these non-GAAP financial measures when they report their operating results. Because of these limitations, these non-GAAP financial measures should be considered along with other operating and financial performance measures presented in accordance with GAAP.
|
||||||||||||||||
Consolidated Statements of Operations and Comprehensive Income (Loss) |
||||||||||||||||
(In thousands) |
||||||||||||||||
|
Three Months Ended |
|
Six Months Ended |
|||||||||||||
|
|
|
|
|
|
|
|
|||||||||
|
(Unaudited) |
|
(Unaudited) |
|
(Unaudited) |
|
(Unaudited) |
|||||||||
REVENUE |
|
|
|
|
|
|
|
|||||||||
Sales of product |
$ |
213,969 |
|
|
$ |
140,556 |
|
|
$ |
411,274 |
|
|
$ |
262,253 |
|
|
Sales of services |
|
33,745 |
|
|
|
33,626 |
|
|
|
65,960 |
|
|
|
64,754 |
|
|
Total revenue |
|
247,714 |
|
|
|
174,182 |
|
|
|
477,234 |
|
|
|
327,007 |
|
|
Cost of Sales |
|
163,733 |
|
|
|
114,988 |
|
|
|
316,684 |
|
|
|
214,519 |
|
|
GROSS PROFIT |
|
83,981 |
|
|
|
59,194 |
|
|
|
160,550 |
|
|
|
112,488 |
|
|
OPERATING EXPENSE |
|
|
|
|
|
|
|
|||||||||
Selling and marketing |
|
14,389 |
|
|
|
10,381 |
|
|
|
27,739 |
|
|
|
19,840 |
|
|
General and administrative |
|
29,743 |
|
|
|
36,936 |
|
|
|
57,849 |
|
|
|
56,522 |
|
|
Contingent consideration and earnout fair value adjustments |
|
— |
|
|
|
687 |
|
|
|
— |
|
|
|
687 |
|
|
Operating Expenses |
|
44,132 |
|
|
|
48,004 |
|
|
|
85,588 |
|
|
|
77,049 |
|
|
INCOME FROM OPERATIONS |
|
39,849 |
|
|
|
11,190 |
|
|
|
74,962 |
|
|
|
35,439 |
|
|
Interest expense |
|
(8,868 |
) |
|
|
(7,476 |
) |
|
|
(17,643 |
) |
|
|
(15,602 |
) |
|
Other expense |
|
(342 |
) |
|
|
(919 |
) |
|
|
(369 |
) |
|
|
(2,478 |
) |
|
Change in fair value of derivative warrant liabilities |
|
— |
|
|
|
(1,929 |
) |
|
|
— |
|
|
|
(1,929 |
) |
|
INCOME BEFORE TAXES |
|
30,639 |
|
|
|
866 |
|
|
|
56,950 |
|
|
|
15,430 |
|
|
Provision (benefit) for Income Taxes |
|
7,802 |
|
|
|
2,560 |
|
|
|
14,409 |
|
|
|
2,405 |
|
|
NET INCOME (LOSS) |
$ |
22,837 |
|
|
$ |
(1,694 |
) |
|
$ |
42,541 |
|
|
$ |
13,025 |
|
|
Other Comprehensive Income (Loss) |
|
(3,387 |
) |
|
|
(37 |
) |
|
|
(3,901 |
) |
|
|
274 |
|
|
COMPREHENSIVE INCOME (LOSS) |
$ |
19,450 |
|
|
$ |
(1,731 |
) |
|
$ |
38,640 |
|
|
$ |
13,299 |
|
|
Net income (loss) attributable to common stockholders |
$ |
22,837 |
|
|
$ |
(1,694 |
) |
|
$ |
42,541 |
|
|
$ |
13,025 |
|
|
Weighted-average shares outstanding, basic and diluted |
|
|
|
|
|
|
|
|||||||||
Basic |
|
146,575,720 |
|
|
|
81,009,261 |
|
|
|
146,568,719 |
|
|
|
73,577,447 |
|
|
Diluted |
|
146,717,937 |
|
|
|
81,009,261 |
|
|
|
146,648,306 |
|
|
|
73,879,851 |
|
|
Net income (loss) per share, basic and diluted |
|
|
|
|
|
|
|
|||||||||
Basic |
$ |
0.16 |
|
|
$ |
(0.02 |
) |
|
$ |
0.29 |
|
|
$ |
0.18 |
|
|
Diluted |
$ |
0.16 |
|
|
$ |
(0.02 |
) |
|
$ |
0.29 |
|
|
$ |
0.18 |
|
|
|
||||||||
Consolidated Balance Sheets |
||||||||
(In thousands) |
||||||||
|
|
|
|
|||||
|
2022 |
|
2022 |
|||||
|
(Unaudited) |
|
|
|||||
|
|
|
|
|||||
ASSETS |
|
|
|
|||||
Current Assets |
|
|
|
|||||
Cash and cash equivalents |
$ |
40,718 |
|
|
$ |
13,192 |
|
|
Accounts receivable, less allowance for credit losses; |
$ |
132,531 |
|
|
$ |
107,372 |
|
|
Costs and estimated earnings in excess of billing on uncompleted contracts |
$ |
21,715 |
|
|
$ |
23,121 |
|
|
Inventory, net |
$ |
66,769 |
|
|
$ |
56,596 |
|
|
Prepaid expenses |
$ |
8,211 |
|
|
$ |
9,843 |
|
|
Other current assets |
$ |
3,288 |
|
|
$ |
4,057 |
|
|
Total current assets |
$ |
273,232 |
|
|
$ |
214,181 |
|
|
Right-of-use assets, net |
$ |
40,535 |
|
|
$ |
— |
|
|
Property and equipment, net |
$ |
42,557 |
|
|
$ |
41,607 |
|
|
Customer relationships, net |
$ |
296,779 |
|
|
$ |
312,199 |
|
|
Tradename and trademarks |
$ |
107,403 |
|
|
$ |
107,980 |
|
|
Other intangibles, net |
$ |
15,118 |
|
|
$ |
15,861 |
|
|
|
$ |
368,085 |
|
|
$ |
369,286 |
|
|
Deferred tax asset, net |
$ |
60,005 |
|
|
$ |
58,915 |
|
|
Other assets, net |
$ |
1,825 |
|
|
$ |
1,973 |
|
|
Total assets |
$ |
1,205,539 |
|
|
$ |
1,122,002 |
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
|||||
Current Liabilities |
|
|
|
|||||
Accounts payable |
$ |
56,425 |
|
|
$ |
54,961 |
|
|
Billing in excess of costs and estimated earnings on uncompleted contracts |
$ |
26,084 |
|
|
$ |
23,207 |
|
|
Current maturities of long-term debt |
$ |
8,229 |
|
|
$ |
8,067 |
|
|
Other accrued expenses |
$ |
65,958 |
|
|
$ |
54,111 |
|
|
Total current liabilities |
$ |
156,696 |
|
|
$ |
140,346 |
|
|
Line of credit |
$ |
— |
|
|
$ |
6,369 |
|
|
Long-term debt, net |
$ |
701,883 |
|
|
$ |
703,718 |
|
|
Deferred tax liability, net |
$ |
1,827 |
|
|
$ |
749 |
|
|
Other long-term liabilities |
$ |
37,620 |
|
|
$ |
2,533 |
|
|
Total liabilities |
$ |
898,026 |
|
|
$ |
853,715 |
|
|
STOCKHOLDERS’ EQUITY |
|
|
|
|||||
Common Stock, 825,000,000 shares authorized, |
$ |
15 |
|
|
$ |
15 |
|
|
Additional paid-in capital |
$ |
279,309 |
|
|
$ |
277,799 |
|
|
Accumulated other comprehensive loss |
$ |
(4,850 |
) |
|
$ |
(949 |
) |
|
Accumulated surplus (deficit) |
$ |
33,039 |
|
|
$ |
(8,578 |
) |
|
Total stockholders’ equity |
$ |
307,513 |
|
|
$ |
268,287 |
|
|
Total liabilities and stockholders’ equity |
$ |
1,205,539 |
|
|
$ |
1,122,002 |
|
|
|
||||||||
Consolidated Statements of Cash Flows |
||||||||
(In thousands) |
||||||||
|
Six Months Ended |
|||||||
|
|
|
|
|||||
|
(Unaudited) |
|
(Unaudited) |
|||||
Cash Flows Provided By Operating Activities |
|
|
|
|||||
Net income |
$ |
42,541 |
|
|
$ |
13,025 |
|
|
Adjustments to reconcile net income to net cash provided by operating activities |
|
|
|
|||||
Depreciation of property and equipment |
|
3,835 |
|
|
|
2,979 |
|
|
Reduction in carrying amount of right-of-use assets |
|
2,615 |
|
|
|
— |
|
|
Intangible amortization |
|
14,871 |
|
|
|
13,623 |
|
|
Deferred finance fee amortization |
|
1,832 |
|
|
|
1,487 |
|
|
Provision for losses on accounts receivable |
|
1,158 |
|
|
(666 |
) |
||
Share based compensation |
|
1,510 |
|
|
|
5,262 |
|
|
Loss on extinguishment of debt |
|
— |
|
|
|
2,415 |
|
|
Change in fair value of contingent consideration |
|
— |
|
|
|
687 |
|
|
(Gain) Loss on sale of assets |
|
(28 |
) |
|
|
43 |
|
|
Loss on abandonment of PP&E |
|
571 |
|
|
|
— |
|
|
Change in fair value of derivative warrant liabilities |
|
— |
|
|
|
1,929 |
|
|
Undistributed (earnings) losses of affiliate |
|
(60 |
) |
|
|
(105 |
) |
|
Deferred income taxes |
|
— |
|
|
|
(768 |
) |
|
Changes in operating assets and liabilities |
|
|
|
|||||
Accounts receivable |
|
(26,682 |
) |
|
|
(3,756 |
) |
|
Costs and estimated earnings in excess of billings and billings in excess of costs and estimated earnings on uncompleted contracts |
|
1,406 |
|
|
|
(5,216 |
) |
|
Prepaid expenses and other current assets |
|
2,481 |
|
|
|
(2,946 |
) |
|
Inventory |
|
(10,173 |
) |
|
|
(11,008 |
) |
|
Accounts payable |
|
1,464 |
|
|
|
15,393 |
|
|
Other accrued expenses |
|
6,971 |
|
|
|
13,783 |
|
|
Other assets and long-term liabilities |
|
(1,160 |
) |
|
|
(1,338 |
) |
|
Net Cash Provided By Operating Activities |
$ |
43,152 |
|
|
$ |
44,823 |
|
|
Cash Flows Used In Investing Activities |
|
|
|
|||||
Proceeds from sale of equipment |
$ |
45 |
|
|
$ |
79 |
|
|
Purchases of property and equipment |
|
(5,268 |
) |
|
|
(3,993 |
) |
|
Cash paid for acquisition, net of cash acquired |
|
— |
|
|
|
(1,565 |
) |
|
|
$ |
(5,223 |
) |
|
$ |
(5,479 |
) |
|
Cash Flows Used In Financing Activities |
|
|
|
|||||
Repayments on line of credit |
$ |
(6,369 |
) |
|
$ |
— |
|
|
Distributions to |
|
— |
|
|
|
(4,174 |
) |
|
Principal payments on long-term debt |
|
(4,034 |
) |
|
|
(63,238 |
) |
|
Proceeds from merger |
|
— |
|
|
|
334,874 |
|
|
Proceeds from PIPE |
|
— |
|
|
|
250,000 |
|
|
Payments for transaction costs, net |
|
— |
|
|
|
(44,489 |
) |
|
Payments to |
|
— |
|
|
|
(541,710 |
) |
|
Principal payments under capital lease obligations |
|
(66 |
) |
|
|
— |
|
|
Payments for deferred financing fees |
|
— |
|
|
|
(766 |
) |
|
Cash Used In Financing Activities |
$ |
(10,469 |
) |
|
$ |
(69,503 |
) |
|
Effect of exchange rate changes on cash and cash equivalents |
$ |
66 |
|
|
$ |
191 |
|
|
Net (Decrease) Increase in Cash and Cash Equivalents |
$ |
27,526 |
|
|
$ |
(29,968 |
) |
|
Cash and Cash Equivalents, Beginning of Period |
$ |
13,192 |
|
|
$ |
45,255 |
|
|
Cash and Cash Equivalents, End of Period |
$ |
40,718 |
|
|
$ |
15,287 |
|
|
Supplemental Cash Flows Information |
|
|
|
|||||
Interest paid |
$ |
18,296 |
|
|
$ |
16,848 |
|
|
Income taxes paid |
$ |
11,889 |
|
|
$ |
774 |
|
|
Cash paid for operating leases |
$ |
3,832 |
|
|
$ |
— |
|
|
Fair value of earnout |
$ |
— |
|
|
$ |
687 |
|
|
Fair value of warrants |
$ |
— |
|
|
$ |
1,929 |
|
|
Non-cash investing and financing activities: |
|
|
|
|||||
Right-of-use assets obtained in exchange for operating lease obligations |
$ |
42,380 |
|
|
$ |
— |
|
|
Right-of-use assets obtained in exchange for finance lease obligations |
$ |
706 |
|
|
$ |
— |
|
|
|
||||||||||||||
Reconciliation of Net Income to Adjusted EBITDA |
||||||||||||||
(In thousands) |
||||||||||||||
|
Three Months Ended |
|
|
|
|
|||||||||
|
|
|
|
|
Variance |
|||||||||
|
|
|
$ |
|
% |
|||||||||
|
|
|
|
|
|
|
|
|||||||
Net Income |
$ |
22,837 |
|
$ |
(1,694 |
) |
|
$ |
24,531 |
|
|
1448.1 |
% |
|
Interest Expense |
|
8,868 |
|
|
7,476 |
|
|
|
1,392 |
|
|
18.6 |
% |
|
Income Taxes |
|
7,802 |
|
|
2,560 |
|
|
|
5,242 |
|
|
204.8 |
% |
|
Depreciation |
|
1,978 |
|
|
1,506 |
|
|
|
472 |
|
|
31.3 |
% |
|
Amortization |
|
7,646 |
|
|
6,791 |
|
|
|
855 |
|
|
12.6 |
% |
|
EBITDA |
$ |
49,131 |
|
$ |
16,639 |
|
|
$ |
32,492 |
|
|
195.3 |
% |
|
Loss (gain) on extinguishment of debt(1) |
|
— |
|
|
994 |
|
|
|
(994 |
) |
|
(100.0 |
)% |
|
COVID-19 related expenses(2) |
|
— |
|
|
13 |
|
|
|
(13 |
) |
|
(100.0 |
)% |
|
Transaction related expenses(3) |
|
— |
|
|
10,398 |
|
|
|
(10,398 |
) |
|
(100.0 |
)% |
|
Facility relocation(4) |
|
517 |
|
|
49 |
|
|
|
468 |
|
|
955.1 |
% |
|
Share-based compensation(5) |
|
— |
|
|
5,210 |
|
|
|
(5,210 |
) |
|
(100.0 |
)% |
|
Acquisition expense(6) |
|
535 |
|
|
— |
|
|
|
535 |
|
|
100.0 |
% |
|
Severance and transition costs (7) |
|
500 |
|
|
— |
|
|
|
500 |
|
|
100.0 |
% |
|
Change in fair value of contingent consideration(8) |
|
— |
|
|
687 |
|
|
|
(687 |
) |
|
(100.0 |
)% |
|
Change in fair value of derivative warrant liabilities(9) |
|
— |
|
|
1,929 |
|
|
|
(1,929 |
) |
|
(100.0 |
)% |
|
Adjusted EBITDA |
$ |
50,683 |
|
$ |
35,919 |
|
|
$ |
14,764 |
|
|
41.1 |
% |
|
|
Six Months Ended |
|
|
|
|
|||||||||
|
|
|
|
|
Variance |
|||||||||
|
|
|
$ |
|
% |
|||||||||
|
|
|
|
|
|
|
|
|||||||
Net Income |
$ |
42,541 |
|
$ |
13,025 |
|
|
$ |
29,516 |
|
|
226.6 |
% |
|
Interest Expense |
|
17,643 |
|
|
15,602 |
|
|
|
2,041 |
|
|
13.1 |
% |
|
Income Taxes |
|
14,409 |
|
|
2,405 |
|
|
|
12,004 |
|
|
499.1 |
% |
|
Depreciation |
|
3,835 |
|
|
2,979 |
|
|
|
856 |
|
|
28.7 |
% |
|
Amortization |
|
14,871 |
|
|
13,623 |
|
|
|
1,248 |
|
|
9.2 |
% |
|
EBITDA |
$ |
93,299 |
|
$ |
47,634 |
|
|
$ |
45,665 |
|
|
95.9 |
% |
|
Loss (gain) on extinguishment of debt(1) |
|
— |
|
|
2,415 |
|
|
|
(2,415 |
) |
|
(100.0 |
)% |
|
COVID-19 related expenses(2) |
|
109 |
|
|
209 |
|
|
|
(100 |
) |
|
(47.8 |
)% |
|
Transaction related expenses(3) |
|
— |
|
|
10,398 |
|
|
|
(10,398 |
) |
|
(100.0 |
)% |
|
Facility relocation(4) |
|
620 |
|
|
67 |
|
|
|
553 |
|
|
825.4 |
% |
|
Share-based compensation(5) |
|
— |
|
|
5,210 |
|
|
|
(5,210 |
) |
|
(100.0 |
)% |
|
Acquisition expense(6) |
|
821 |
|
|
— |
|
|
|
821 |
|
|
100.0 |
% |
|
Severance and transition costs (7) |
|
500 |
|
|
— |
|
|
|
500 |
|
|
100.0 |
% |
|
Change in fair value of contingent consideration(8) |
|
— |
|
|
687 |
|
|
|
(687 |
) |
|
(100.0 |
)% |
|
Change in fair value of derivative warrant liabilities(9) |
|
— |
|
|
1,929 |
|
|
|
(1,929 |
) |
|
(100.0 |
)% |
|
Adjusted EBITDA |
$ |
95,349 |
|
$ |
68,549 |
|
|
$ |
26,800 |
|
|
39.1 |
% |
(1) |
Adjustment for loss (gain) on extinguishment of debt regarding the write off of unamortized fees and third-party fees as a result of the debt modification completed in |
|
(2) |
Expenses which are one-time and non-recurring related to the COVID-19 pandemic. See Impact of COVID-19 section. |
|
(3) |
Transaction related expenses incurred as a result of the Business Combination on |
|
(4) |
Expenses related to the facility relocation for ASTA and |
|
(5) |
Share-based compensation expense associated with Midco, LLC Class |
|
(6) |
Expenses related to the transition services agreement for the DBCI acquisition which closed |
|
(7) |
Reflects one-time costs associated with our strategic transformation, including executive leadership team changes, strategic business assessment and transformation projects. |
|
(8) |
Adjustment related to the change in fair value of contingent consideration related to the earnout of the 2,000,000 common stock shares that were issued and released on |
|
(9) |
Adjustment related to the change in fair value of derivative warrant liabilities for the private placement warrants. |
|
|
|||||||
Reconciliation of Net Income to Non-GAAP Adjusted Net Income |
|||||||
(In thousands) |
|||||||
|
Three Months Ended |
||||||
|
|
|
|
||||
Net Income (Loss) |
$ |
22,837 |
|
$ |
(1,694 |
) |
|
Net Income Adjustments(1) |
|
1,552 |
|
|
19,279 |
|
|
Tax Effect Non-GAAP on Net Income Adjustments(2) |
|
393 |
|
|
3,005 |
|
|
Non-GAAP Adjusted Net Income |
$ |
24,782 |
|
$ |
20,590 |
|
|
|
Six Months Ended |
||||||
|
|
|
|
||||
Net Income |
$ |
42,541 |
|
$ |
13,025 |
|
|
Net Income Adjustments(1) |
|
2,051 |
|
|
20,914 |
|
|
Tax Effect Non-GAAP on Net Income Adjustments(2) |
|
519 |
|
|
3,260 |
|
|
Non-GAAP Adjusted Net Income |
$ |
45,111 |
|
$ |
37,199 |
(1) |
Refer to |
|
(2) |
Tax effected for the net income adjustments. Used effective tax rates |
|
|
||||||
Non-GAAP Adjusted EPS |
||||||
(In thousands) |
||||||
|
|
|||||
|
Three Months Ended |
|||||
|
|
|
|
|||
Numerator: |
|
|
|
|||
Non-GAAP Adjusted Net Income |
$ |
24,782 |
|
$ |
20,590 |
|
Denominator: |
|
|
|
|||
Weighted average number of shares: |
|
|
|
|||
Basic |
|
146,575,720 |
|
|
81,009,261 |
|
Adjustment for Restricted Stock Units |
|
142,217 |
|
|
— |
|
Diluted |
|
146,717,937 |
|
|
81,009,261 |
|
Non-GAAP Adjusted Basic EPS |
$ |
0.17 |
|
$ |
0.25 |
|
Non-GAAP Adjusted Diluted EPS |
$ |
0.17 |
|
$ |
0.25 |
|
|
|
|||||
|
Six Months Ended |
|||||
|
|
|
|
|||
Numerator: |
|
|
|
|||
Non-GAAP Adjusted Net Income |
$ |
45,111 |
|
$ |
37,199 |
|
Denominator: |
|
|
|
|||
Weighted average number of shares: |
|
|
|
|||
Basic |
|
146,568,719 |
|
|
73,577,447 |
|
Adjustment for Restricted Stock Units |
|
79,587 |
|
|
302,404 |
|
Diluted |
|
146,648,306 |
|
|
73,879,851 |
|
Non-GAAP Adjusted Basic EPS |
$ |
0.31 |
|
$ |
0.51 |
|
Non-GAAP Adjusted Diluted EPS |
$ |
0.31 |
|
$ |
0.50 |
|
|
||||||||
Non-GAAP Free Cash Flow Conversion |
||||||||
(In thousands) |
||||||||
|
Three Months Ended |
|||||||
|
|
|
|
|||||
Cash flow from operating activities |
$ |
18,377 |
|
|
$ |
19,263 |
|
|
Less capital expenditure |
|
(2,388 |
) |
|
|
(1,629 |
) |
|
Free cash flow |
$ |
15,989 |
|
|
$ |
17,634 |
|
|
|
|
|
|
|||||
Non-GAAP Adjusted Net Income |
$ |
24,782 |
|
|
$ |
20,590 |
|
|
|
|
|
|
|||||
Free cash flow conversion of Non-GAAP Adjusted Net Income |
|
65 |
% |
|
|
86 |
% |
|
|
Six Months Ended |
|||||||
|
|
|
|
|||||
Cash flow from operating activities |
$ |
43,152 |
|
|
$ |
44,823 |
|
|
Less capital expenditure |
|
(5,268 |
) |
|
|
(3,993 |
) |
|
Free cash flow |
$ |
37,884 |
|
|
$ |
40,830 |
|
|
|
|
|
|
|||||
Non-GAAP Adjusted Net Income |
$ |
45,111 |
|
|
$ |
37,199 |
|
|
|
|
|
|
|||||
Free cash flow conversion of Non-GAAP Adjusted Net Income |
|
84 |
% |
|
|
110 |
% |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220816005283/en/
Investor Contacts, Janus
Vice President, Investor Relations & FP&A,
IR@janusintl.com
(770) 562-6399
Media Contacts, Janus
Marketing Content Manager,
770-746-9576
Marketing@Janusintl.com
Jason.Chudoba@ICRinc.com
Source:
FAQ
What was Janus International Group's revenue for Q2 2022?
How much did Adjusted EBITDA grow for Janus in Q2 2022?
What is Janus International Group's net income for Q2 2022?
What is the updated full-year 2022 revenue outlook for Janus International Group?